Latest news with #JohnRansom
Business Insider
3 days ago
- Business
- Business Insider
TD Cowen Remains a Hold on UnitedHealth (UNH)
In a report released today, Ryan Langston from TD Cowen reiterated a Hold rating on UnitedHealth (UNH – Research Report), with a price target of $308.00. Confident Investing Starts Here: Langston covers the Healthcare sector, focusing on stocks such as UnitedHealth, P3 Health Partners, and Acadia Healthcare. According to TipRanks, Langston has an average return of -7.2% and a 30.56% success rate on recommended stocks. In addition to TD Cowen, UnitedHealth also received a Hold from Raymond James's John Ransom in a report issued on May 16. However, today, KeyBanc maintained a Buy rating on UnitedHealth (NYSE: UNH). Based on UnitedHealth's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $109.58 billion and a net profit of $6.29 billion. In comparison, last year the company earned a revenue of $98.79 billion and had a GAAP net loss of $1.41 billion Based on the recent corporate insider activity of 147 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of UNH in relation to earlier this year. Last month, Timothy Patrick Flynn, a Director at UNH bought 1,533.00 shares for a total of $491,786.40.
CNBC
14-05-2025
- Health
- CNBC
Raymond James' John Ransom: UnitedHealth will now trade closer to an industry multiple
John Ransom, Raymond James director of healthcare research, joins 'Power Lunch' to discuss why Ransom has pause on shares of UnitedHealth, why the company withdrew its guidance, and much more.
